PRN: Global Diabetic Care Market to Reach $122 Billion by 2022 - Key Vendors are GlaxosmithKline, Abbott Laboratories & Eli Lilly And Company

14/mar/2016 17:10:17 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Diabetic Care Market to Reach $122 Billion by 2022 - Key Vendors are GlaxosmithKline, Abbott Laboratories & Eli Lilly And Company


DUBLIN, March 14, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Global Diabetic Care Market Analysis, 2015 - 2022" report to their offering.

The gradual advancement and innovation of new Diabetic Care technologies are developing a concrete platform for further growth of Diabetic Care market. With the emergence of advanced technologies such as mobile health, precision medicine, smart sensors, wearable technologies, and 3D-printing into the field of Diabetic Care, there has been a rise in the overall demand of the newly developed Diabetic Care products.

Presently, the main focus of the government initiatives is mainly towards developing non-invasive solutions, controlling the level of increase in diabetic population, and integrating advanced technologies to fulfill the unmet needs of the diabetic population.

Governmental regulations and standards are playing a major role in sustaining the growth and development of the Diabetic Care market. The main aim of these regulations is to make Diabetic Care more adaptable and focused towards different types of diabetic diseases and also provide modern mobile technologies to the diabetic population.

The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive the required treatment for the disease. The Diabetic Care market growth is propelled by due to factors such as: increasing demand for non-invasive treatments, technological innovation and advancement, development of artificial pancreas, and government support and regulations.

Throughout the Asia-Pacific region, regulatory bodies are implementing policies to keep a check on latest technologies. The Americas is the largest contributor in the overall revenue generation in Diabetic Care, followed by the European region, and is expected to grow at a CAGR of 8.13% from 2015 to 2022. The Middle Eastern region is expected to show the fastest growth globally, and is expected to grow at 14.79% CAGR from 2015 to 2022. The APAC region is focusing more on technological development and introduction of new advanced tools into Diabetic Care systems, in order to develop specific therapies and solutions.

Key Topics Covered:

1 Report Overview

2 Executive Summary

3 Market Overview

4 Market Dynamics

5 Competitive Insights

6 Industry Analysis

7 Global Diabetic Care Market By Diabetes Types

8 Global Diabetic Care Market By Ecosystem Players

9 Global Diabetic Care Market By Drug Types

10 Global Diabetic Care Market By Device Types

11 Global Diabetic Care Market By Mobile Application Developers

12 Global Diabetic Care Market, By End-Use Application

13 Global Diabetic Care Market, By Geography

14 Global Diabetic Care Market: Key Players

Companies Mentioned:

  • AT&T, Inc.
  • Abbott Laboratories
  • Agamatrix, Inc.
  • AstraZeneca
  • Bayer Healthcare Ag
  • Boehringer Ingelheim Group
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • Glaxosmithkline Plc (GSK)
  • Johnson & Johnson
  • Medtronic Incorporation
  • Merck & Co., Inc
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche Diagnostics
  • Sanofi Pharma
  • Takeda Pharmaceutical Company Limited

For more information visit

Media Contact:

Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl